Relationship between hyperglycaemia at admission and prognosis in patients with acute myocardial infarction: a retrospective cohort study
Related Experiment Video
Updated: Jul 31, 2025

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
Linlin Liu1, Jun Qian1, Wenwen Yan1
1Department of Cardiology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Insights
High blood sugar on admission predicts higher mortality in acute myocardial infarction (AMI) patients, particularly those without diabetes. This finding highlights the importance of glucose management in AMI care.
Area of Science:
- Cardiology
- Endocrinology
- Critical Care Medicine
Background:
- The prognostic significance of admission hyperglycemia in acute myocardial infarction (AMI) remains incompletely understood.
- Optimal glucose thresholds for risk stratification in AMI patients are not well-defined.
Purpose of the Study:
- To determine the optimal admission blood glucose thresholds for predicting mortality in AMI patients.
- To evaluate the impact of hyperglycemia on hospital and 1-year mortality in AMI patients, stratified by diabetes status.
Main Methods:
- Retrospective analysis of 2027 AMI patients from the MIMIC-III database (June 2001-December 2012).
- Receiver operating characteristic (ROC) curve analysis to identify significant blood glucose cut-off values (Glucose_0) for predicting hospital mortality.
- Classification of patients into hyperglycemia and non-hyperglycemia groups based on identified thresholds.
Main Results:
- Admission hyperglycemia was associated with significantly increased hospital mortality in AMI patients, irrespective of diabetes status.
- For AMI patients without diabetes, hyperglycemia independently predicted increased 1-year mortality (HR, 1.47; 95% CI 1.18-1.82).
- The association between hyperglycemia and 1-year mortality was not significant in AMI patients with diabetes (HR, 1.35; 95% CI 0.93-1.95).
Conclusions:
- Admission hyperglycemia serves as an independent predictor of mortality in patients with AMI.
- The prognostic impact of admission hyperglycemia is more pronounced in AMI patients without a history of diabetes.
- These findings underscore the importance of monitoring and managing blood glucose levels in AMI patients for improved clinical outcomes.
Background:
The optimal threshold of hyperglycaemia at admission for identifying high-risk individuals in patients with acute myocardial infarction (AMI) and its impact on clinical prognosis are still unclear.
Methods:
We retrospectively reviewed 2027 patients with AMI admitted from June 2001 to December 2012 in the 'Medical Information Mart for Intensive Care III' database. The significant cut-off values of admission blood glucose (Glucose_0) for predicting hospital mortality in patients with AMI with and without diabetes were obtained from the receiver operating characteristic (ROC) curve, then patients were assigned to hyperglycaemia and non-hyperglycaemia groups based on corresponding cut-off values. The primary endpoints were the hospital and 1-year mortality.
Results:
Among 2027 patients, death occurred in 311 patients (15.3%). According to the ROC curve, the significant cut-off values of Glucose_0 to predict hospital mortality were 224.5 and 139.5 mg/dL in patients with diabetes and without diabetes, respectively. The crude hospital and 1-year mortality of the hyperglycaemia subgroup were higher than the corresponding non-hyperglycaemia group (p< 0.01). After adjustment, regardless of the state of diabetes, hyperglycaemia at admission was related to significantly increased hospital mortality in patients with AMI. For patients with AMI without diabetes, hyperglycaemia at admission was positively correlated with the increase of 1-year mortality (HR, 1.47; 95% CI 1.18 to 1.82; p=0.001). Nevertheless, this trend disappeared in those with diabetes (HR, 1.35; 95% CI 0.93 to 1.95; p=0.113).
Conclusion:
Hyperglycaemia at admission was an independent predictor for mortality during hospitalisation and at 1-year in patients with AMI, especially in patients without diabetes.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Hypoglycemia and Glucagon
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Diabetes: Symptoms, Diagnosis, and Complications
Acute Coronary Syndrome I: Introduction

